Suchergebnisse - "Bisbal, Otilia"

PubPharm (4)

1

Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice

enthalten in: The Journal of antimicrobial chemotherapy | 2023

von Suárez-García, I. | Alejos, B. | Hernando, V. | +111

2

Integrase inhibitors in children and adolescents : clinical use and resistance

enthalten in: The Journal of antimicrobial chemotherapy | 2022

von Torres-Fernandez, D. | Jiménez de Ory, S. | Fortuny, C. | +111

3

Long-term efficacy of dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine : Week 96 results of ART-PRO pilot study

enthalten in: The Journal of antimicrobial chemotherapy | 2021

von Rial-Crestelo, D. | de Miguel, R. | Montejano, R. | +52

4

Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine : 48-week results of a non-randomized, pilot clinical trial (ART-PRO)

enthalten in: EBioMedicine | 2020

von De Miguel, R. | Rial-Crestelo, D. | Dominguez-Dominguez, L. | +20

CommentIn: EBioMedicine. 2020 Jun;56:102820. - PMID 32512519

1
[1]